The Claim
In critically ill patients with COVID-19, intravenous vitamin C administration at a dose of 1.5 grams every 6 hours for up to 4 days is associated with higher in-hospital mortality (88% vs. 79%) and higher post-treatment Sequential Organ Failure Assessment (SOFA) scores (12.4 ± 2.8 vs. 8.1 ± 3.5).
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Critically ill COVID-19 patients receiving intravenous vitamin C at 1.5 grams every 6 hours for up to 4 days had higher rates of death and worse organ failure scores compared to those who did not receive this treatment.
See the scientific wording
In critically ill patients with COVID-19, intravenous vitamin C administration at a dose of 1.5 grams every 6 hours for up to 4 days is associated with higher in-hospital mortality (88% vs. 79%) and higher post-treatment Sequential Organ Failure Assessment (SOFA) scores (12.4 ± 2.8 vs. 8.1 ± 3.5), suggesting a potential link between this intervention and worse clinical outcomes, though causation cannot be established due to study design limitations.
Giving large amounts of vitamin C to very sick patients overwhelms their already stressed bodies, causing harmful chemical reactions that damage cells and organs instead of helping them.
What the research says
1 studyStudy: Use of Intravenous Vitamin C in Critically Ill Patients With COVID-19 Infection
In very sick COVID-19 patients, those given high-dose IV vitamin C were more likely to die and had worse organ damage than those who didn’t get it — but this doesn’t mean the vitamin caused it, just that it was linked to worse results.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.